Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Real-world validation of the molecular prognostic risk signature in acute myeloid leukemia treated with hypomethylating agents plus BCL-2 inhibitor.

Jonathan Andreadakis, Olivia Wilkins, Alexander Shkembi, Amy Wu, John Basile, Anna Krzeczowska, Alexandra Thalberg, Linda Linderbeck, Nidia Zapata, Suzane Silbert, Marci O'Driscoll, Anne Renteria, Maher Albitar, Lacey Williams, Jason Salemi, Amy Alman, Tiphaine Martin, David Swoboda, Gustavo Rivero

Blood (2025) 146 (Supplement 1): 3413.

https://doi.org/10.1182/blood-2025-3413

Published: 2025

Journal Articles

Artificial intelligence‑driven virtual tumor board enhances precision care in Acute Myeloid Leukemia (AML)

David Swoboda, Jiasheng Wang, Thomas Kehoe, Gustavo Rivero, Aziz Nazha

Blood (2025) 146 (Supplement 1): 5176.

https://doi.org/10.1182/blood-2025-5176

Published: 2025

Journal Articles

Maturing progenitor-like immunophenotypic cluster and megakaryocytic repopulating ability predict measurable residual disease in Acute Myeloid Leukemia

Olivia Wilkins, Jonathan Andreadakis, Alexander Shkembi, Amy Wu, John Basile, Anna Krzeczowska, Alexandra Thalberg, Linda Linderbeck, Nidia Zapata, Marci O'Driscoll, Suzane Silbert, Tiphaine Martin, Anne Renteria, Maher Albitar, Lacey Williams, Jason Salemi, Amy Alman, David Swoboda, Gustavo Rivero

Blood (2025) 146 (Supplement 1): 7049.

https://doi.org/10.1182/blood-2025-7049

Published: 2025

Journal Articles

Artificial intelligence‑driven virtual tumor board enhances precision care in myelodysplastic syndromes (MDS)

David Swoboda, Amy DeZern, James England, Sangeetha Venugopal, Thomas Kehoe, Brandon Aubrey, Marco Gabriele Raddi, Angela Consagra, Jiasheng Wang, Gustavo Rivero, Maximilian Stahl, Amer Zeidan, Torsten Haferlach, Andrew Brunner, Rena Buckstein, Valeria Santini, Matteo Della Porta, Mikkael Sekeres, Aziz Nazha

Blood (2025) 146 (Supplement 1): 7363.

https://doi.org/10.1182/blood-2025-7363

Published: 2025

Journal Articles

Evaluating large language models in real-world hematologic clinical decision-making: Performance, limitations, and clinical implications

Blood (2025) 146 (Supplement 1): 4349.

https://doi.org/10.1182/blood-2025-4349

Published: 2025

Journal Articles

Developing artificial intelligence-based transcriptomic signature for selecting patients with HOXA-MEIS1 pathway abnormalities for the treatment with menin inhibitors

Maher Albitar, Hong Zhang, Gustavo Rivero, David Swoboda, Sally Agersborg, Adam Albitar, Ahmad Charifa, Andrew Ip, Andre Goy, Andrew Pecora, David Siegel, Kelly West Fitzpatrick, Katherine Linder, Jamie Koprivnikar, James McCloskey

Blood (2025) 146 (Supplement 1): 3471.

https://doi.org/10.1182/blood-2025-3471

Published: 2025

Journal Articles

Developing transcriptomic signature for IDH1 and IDH2 acute leukemia and the demonstration of high prevalence of these signatures in mutation-negative leukemia

Blood (2025) 146 (Supplement 1): 5251.

https://doi.org/10.1182/blood-2025-5251

Published: 2025

Journal Articles

Integrative clinical and molecular analysis of outcome in elderly African ancestry Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 1733.

https://doi.org/10.1182/blood-2025-1733

Published: 2025

Journal Articles

Glucose-6-phosphatase dehydrogenase [G6PD] serum level predicts acute monocytic leukemia differentiation.

Alexander Shkembi, Jonathan Andreadakis, Olivia Wilkins, Amy Wu, John Basile, Anne Renteria, Anna Krzeczowska, David Swoboda, Alexandra Thalberg, Linda Linderbeck, Nidia Zapata, Maher Albitar, Lacey Williams, Gustavo Rivero

Blood (2025) 146 (Supplement 1): 6902.

https://doi.org/10.1182/blood-2025-6902

Published: 2025

Journal Articles

Is Renal Function Equally Impacted By Hypomethylating Agents during Acute Myelogenous Leukemia Induction Therapy?

Hannah Otiker, Gustavo Rivero, Ashley Sidebottom, Grace Hwang

Blood (2022) 140 (Supplement 1): 3297–3298.

https://doi.org/10.1182/blood-2022-167421

Published: 2022

Journal Articles

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Brandon J Kale, Grace Hwang, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Blood (2022) 140 (Supplement 1): 8934–8935.

https://doi.org/10.1182/blood-2022-170210

Published: 2022

Journal Articles

Dexamethasone during Leukemia Induction Therapy to Reduce Incidence of Acute Myelogenous Leukemia Relapse

Ashley Sidebottom, Hannah Otiker, Purnima Sravanti Teegavarapu, Gustavo Rivero, Grace Hwang

Blood (2022) 140 (Supplement 1): 9032–9033.

https://doi.org/10.1182/blood-2022-162768

Published: 2022

Journal Articles

Predictive Ability of Coronary Artery Disease on Age Acceleration and Clinical Outcome in Adult Acute Myelogenous Leukemia

Ximena Melhado Basurto, Gustavo Rivero, Carlos José Fajardo, Purnima Sravanti Teegavarapu, Nidia Paulina Zapata, Victor Itaí Urbalejo Ceniceros, Karen Heyly Vallejo

Blood (2022) 140 (Supplement 1): 11621–11622.

https://doi.org/10.1182/blood-2022-162314

Published: 2022

Journal Articles

Specific Nucleotide Substitutions and Stressors Erode Highly Conserved Genomic Regions in Acute Myelogenous Leukemia

Nikhil Patel, Gustavo Rivero, Martha P. Mims, Purnima Sravanti Teegavarapu, Gianfranco Bittar, Diana De Oliviera

Blood (2022) 140 (Supplement 1): 6112–6113.

https://doi.org/10.1182/blood-2022-171086

Published: 2022

Journal Articles

Uncovering Ethnic Genomic Disparities Associated with Inferior Outcome in African Americans Diagnosed with Acute Myelogenous Leukemia

Alexis K Williams, Sergio Abraham, Gianfranco Bittar, Diana De Oliveira, Purnima Sravanti Teegavarapu, Gustavo Rivero

Blood (2022) 140 (Supplement 1): 9128–9129.

https://doi.org/10.1182/blood-2022-159232

Published: 2022

Journal Articles

Predictors of Inferior Survival in African American Patients with Diffuse Large B-Cell Lymphoma

Kevin Tang, Heidi M Krause, Nikhil Patel, Grace Hwang, Jason Lu, Martha P. Mims, Mark M. Udden, Courtney Nicole Miller-Chism, Gustavo Rivero, Purnima Sravanti Teegavarapu

Blood (2022) 140 (Supplement 1): 8101–8102.

https://doi.org/10.1182/blood-2022-168224

Published: 2022

Journal Articles

Inferior Outcome in Non-Adult Young Adolescent B-Cell Acute Lymphoblastic Leukemia Exhibiting Obesity

Karen Heyly Vallejo, Quetzali Hernandez, Jason Lu, Victor Itaí Urbalejo Ceniceros, Purnima Sravanti Teegavarapu, Gustavo Rivero, Nidia Paulina Zapata

Blood (2022) 140 (Supplement 1): 6042–6043.

https://doi.org/10.1182/blood-2022-157190

Published: 2022

Journal Articles

Tobacco Use Predicts Unique Mutagenesis Signature in Acute Myelogenous Leukemia

Tran Hoang, Gianfranco Bittar, Purnima Sravanti Teegavarapu, Martha P. Mims, Gustavo Rivero

Blood (2021) 138 (Supplement 1): 1297.

https://doi.org/10.1182/blood-2021-154173

Published: 2021

Journal Articles

Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

Sara Taveras Alam, Deepa Dongarwar, Elyse Lopez, Sarvari Venkata Yellapragada, Gustavo Rivero, Courtney Nicole Miller-Chism, Martha P. Mims, Quillan Huang, Hamisu Salihu

Blood (2021) 138 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2021-153029

Published: 2021

Journal Articles

Comorbidity Evaluation Identifies Smoking Dose Density to be Associated with TP53 Mutation in Myeloid Malignancies

Alexis K Williams, Iberia R. Sosa, Purnima Sravanti Teegavarapu, Gustavo Rivero

Blood (2021) 138 (Supplement 1): 4450.

https://doi.org/10.1182/blood-2021-151782

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Real-world validation of the molecular prognostic risk signature in acute myeloid leukemia treated with hypomethylating agents plus BCL-2 inhibitor.

Artificial intelligence‑driven virtual tumor board enhances precision care in Acute Myeloid Leukemia (AML)

Maturing progenitor-like immunophenotypic cluster and megakaryocytic repopulating ability predict measurable residual disease in Acute Myeloid Leukemia

Artificial intelligence‑driven virtual tumor board enhances precision care in myelodysplastic syndromes (MDS)

Evaluating large language models in real-world hematologic clinical decision-making: Performance, limitations, and clinical implications

Developing artificial intelligence-based transcriptomic signature for selecting patients with HOXA-MEIS1 pathway abnormalities for the treatment with menin inhibitors

Developing transcriptomic signature for IDH1 and IDH2 acute leukemia and the demonstration of high prevalence of these signatures in mutation-negative leukemia

Integrative clinical and molecular analysis of outcome in elderly African ancestry Acute Myeloid Leukemia

Glucose-6-phosphatase dehydrogenase [G6PD] serum level predicts acute monocytic leukemia differentiation.

Is Renal Function Equally Impacted By Hypomethylating Agents during Acute Myelogenous Leukemia Induction Therapy?

A Real-World Single-Institution Experience with Hypomethylating Agents Plus BCL-2 Inhibitor for the Treatment of Acute Myeloid Leukemia

Dexamethasone during Leukemia Induction Therapy to Reduce Incidence of Acute Myelogenous Leukemia Relapse

Predictive Ability of Coronary Artery Disease on Age Acceleration and Clinical Outcome in Adult Acute Myelogenous Leukemia

Specific Nucleotide Substitutions and Stressors Erode Highly Conserved Genomic Regions in Acute Myelogenous Leukemia

Uncovering Ethnic Genomic Disparities Associated with Inferior Outcome in African Americans Diagnosed with Acute Myelogenous Leukemia

Predictors of Inferior Survival in African American Patients with Diffuse Large B-Cell Lymphoma

Inferior Outcome in Non-Adult Young Adolescent B-Cell Acute Lymphoblastic Leukemia Exhibiting Obesity

Tobacco Use Predicts Unique Mutagenesis Signature in Acute Myelogenous Leukemia

Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities

Comorbidity Evaluation Identifies Smoking Dose Density to be Associated with TP53 Mutation in Myeloid Malignancies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only